Merrimack Pharmaceutical’s MM-111 Granted Orphan Drug Status

barbara.lempert Merrimack Pharmaceutical’s MM-111 Granted Orphan Drug Status by FDA For Treatment of Advanced Gastric and Esophageal Cancers CAMBRIDGE, Mass., Aug. 13, 2013 ...

Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassch

barbara.lempert       Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations NORTHVALE, N.J., Aug. 12, 2013 (GLOBE NEWSWIRE) ...

Lexicon Pharmaceuticals, Others Form Scientific Collaboration

barbara.lempert Howard Hughes Medical Institute, Lexicon Pharmaceuticals, Nuevolution and Leading Research University Form Scientific Collaboration Copenhagen, Denmark, August 12, ...

Sagent Pharmaceuticals Announces the Reintroduction of Amiodarone HCl Injection

barbara.lempert SCHAUMBURG, Ill., Aug. 5, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the reintroduction of Amiodarone HCl Injection, an ...

Sagent Pharmaceuticals Launches Docetaxel Injection Concentrate

barbara.lempert Sagent Pharmaceuticals Announces the Launch of Docetaxel Injection Concentrate SCHAUMBURG, Ill., July 31, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. ...

Isis Pharmaceuticals Earns $2 Million from GSK

barbara.lempert Isis Pharmaceuticals Earns $ 2 Million from GSK for the Advancement of ISIS-TTR Rx CARLSBAD, Calif., July 30, 2013 /PRNewswire/ — Isis Pharmaceuticals, ...

Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for Belviq

barbara.lempert Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Taiwan SAN DIEGO, July 25, 2013 /PRNewswire/ — ...

Endo Health Solutions Names COO of Pharmaceuticals

barbara.lempert Endo Health Solutions Names Don DeGolyer Chief Operating Officer of Pharmaceuticals MALVERN, Pa., July 22, 2013 /PRNewswire/ — Endo Health Solutions Inc. (Nasdaq: ...

GW Pharmaceuticals Files to Expand Sativex in France

barbara.lempert GW Pharmaceuticals Files New Regulatory Application to Expand Sativex® Approval to France LONDON, July 22, 2013 /PRNewswire/ — GW Pharmaceuticals plc ...

Bellicum Pharmaceuticals Initiates Clinical Trial

barbara.lempert Bellicum Pharmaceuticals Initiates Clinical Trial with Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer   Houston, ...

RXi Pharmaceuticals Shares Positive Data for RXi -109

mia.burns RXi Pharmaceuticals Announces Positive Data in Second Phase 1 Multi-Dose Study Data from RXi’s Phase 1 studies, as well as plans for RXI-109 development and other potential ...

ISA Pharmaceuticals Strengthens Management Team

barbara.lempert •    Company hires Jan Fagerberg as Chief Medical Officer and Jens Hennecke as Chief Business Officer •    Ronald Loggers becomes Acting Chief Executive ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS